Pages that link to "Q40817213"

The following pages link to Seven days of ceftriaxone therapy is as effective as ten days' treatment for bacterial meningitis (Q40817213):

Displaying 30 items.

• Short-duration versus standard-duration antibiotic regimens for the treatment of neonatal bacterial infection (Q24186653) (← links)
• Bacterial meningitis: current controversies in approaches to treatment (Q34458384) (← links)
• Antibiotic treatment for bacterial meningitis in children in developing countries (Q35635850) (← links)
• Bacterial meningitis in children: critical review of current concepts (Q36133786) (← links)
• Use of Antimicrobial Agents to Treat Central Nervous System Infection (Q36334000) (← links)
• Current concepts in the treatment of bacterial meningitis beyond the neonatal period. (Q36607421) (← links)
• Therapy of community-acquired acute bacterial meningitis: the clock is running. (Q37614552) (← links)
• Third generation cephalosporins: safety profiles after 10 years of clinical use. (Q37928639) (← links)
• Bacterial meningitis: current therapy and possible future treatment options (Q37949641) (← links)
• Antibiotic duration and timing of the switch from intravenous to oral route for bacterial infections in children: systematic review and guidelines (Q38870252) (← links)
• Novel approaches to therapy of meningitis (Q38960711) (← links)
• Acute neurologic infections. (Q39457589) (← links)
• Ceftriaxone. A reappraisal of its antibacterial activity and pharmacokinetic properties, and an update on its therapeutic use with particular reference to once-daily administration (Q39525936) (← links)
• Update on bacterial meningitis (Q39642835) (← links)
• Bacterial meningitis in children: diagnosis and therapy. A review of recent developments (Q39665730) (← links)
• Variation in paediatric hospital antibiotic guidelines in Europe. (Q40488754) (← links)
• Bacterial meningitis. Practical guidelines for management (Q40961273) (← links)
• Evaluation of duration of antibiotic therapy in neonatal bacterial meningitis: a randomized controlled trial (Q41436067) (← links)
• Comparative efficacy of ceftriaxone and cefuroxime for treatment of bacterial meningitis (Q42195820) (← links)
• Successful shortening from seven to four days of parenteral beta-lactam treatment for common childhood infections: a prospective and randomized study (Q43564023) (← links)
• Short course single daily ceftriaxone monotherapy for acute bacterial meningitis in children: results of a Swiss multicenter study. Part I: Clinical results (Q44261815) (← links)
• 5 versus 10 days of treatment with ceftriaxone for bacterial meningitis in children: a double-blind randomised equivalence study (Q46297381) (← links)
• Role of corticoids in purulent meningitis in children: analysis of literature studies (Q50511770) (← links)
• Bacterial meningitis: is there a "best" antimicrobial therapy? (Q54118200) (← links)
• Development of pneumococcal meningitis during ceftriaxone therapy. (Q54239109) (← links)
• Ceftriaxone in the treatment of meningitis, gonococcal infections and other serious bacterial infections. Infectious Diseases and Immunization Committee, Canadian Paediatric Society (Q68706902) (← links)
• Therapy for bacterial meningitis: which drugs, and for how long? (Q68996148) (← links)
• Impact of cefotaxime and ceftriaxone on the bowel and vaginal flora after single-dose prophylaxis in vaginal hysterectomy (Q70396954) (← links)
• Five days of antibacterial therapy for bacterial meningitis in children? (Q71920279) (← links)
• Surviving sepsis campaign international guidelines for the management of septic shock and sepsis-associated organ dysfunction in children (Q89586654) (← links)